Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients

Transplant International

Volumn 25, Issue 6, 2012, Pages 663-670

  Buob, David ^a,b   Grimbert, Philippe ^c   Glowacki, François ^a   Labalette, Myriam ^a,b   Dufossé, Françoise ^a   Nochy, Dominique ^d   Copin, Marie Christine ^a,b   Boleslawski, Emmanuel ^a   Noël, Christian ^a,b   Hazzan, Marc ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

antibody mediated rejection; glomerulitis; HLA antibody; protocol biopsies

Indexed keywords

CREATININE; CYCLOSPORIN; HLA ANTIBODY; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DONOR SELECTION; FEMALE; FOLLOW UP; GLOMERULITIS; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84861182248     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01473.x     Document Type: Conference Paper

References (36)

1. Heilman RL, Devarapalli Y, Chakkera HA, et al. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant 2010; 10: 563.
2. El-Amm JM, Gruber SA,. The significance of subclinical rejection. Clin Transplant 2009; 23: 150.
3. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
4. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779.
5. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF,. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, analysis using the Banff grading schema. Transplantation 1996; 61: 1586.
6. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
7. Colvin RB,. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046.
8. Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576.
9. Gloor JM, Cosio FG, Rea DJ, et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 1841.
10. Kraus ES, Parekh RS, Oberai P, et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant 2009; 9: 1826.
11. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561.
12. Anglicheau D, Loupy A, Suberbielle C, et al. Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot study. Am J Transplant 2007; 7: 1185.
13. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
14. Buob D, Hazan M, Homs S, et al. Intrarenal IFN-β mRNA expression differentiates clinical and subclinical glomerulitis in renal transplant recipients. Transplantation 2011; 92: 170.
15. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
16. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
17. Gough J, Rush D, Jeffery J, et al. Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. Nephrol Dial Transplant 2002; 17: 1081.
18. Marcussen N, Solez K, Spencer E, Cockfield S, Olsen S,. Early transplant glomerulitis: glomerular size and ultrastructure. Transplant Proc 1996; 28: 468.
19. Messias NC, Eustace JA, Zachary AA, Tucker PC, Charney D, Racusen LC,. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001; 72: 655.
20. Olsen S, Spencer E, Cockfield S, Marcussen N, Solez K,. Endocapillary glomerulitis in the renal allograft. Transplantation 1995; 59: 1421.
21. Colvin RB, Cohen AH, Saiontz C, et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 1930.
22. Maryniak RK, First MR, Weiss MA,. Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 1985; 27: 799.
23. Batal I, Lunz III JG, Aggarwal N, et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 2010; 10: 2442.
24. Richardson WP, Colvin RB, Cheeseman SH, et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 1981; 305: 57.
25. Herrera GA, Alexander RW, Cooley CF, et al. Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int 1986; 29: 725.
26. Birk PE, Chavers BM,. Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol 1997; 8: 1801.
27. Hara S, Matsushita H, Yamaguchi Y, Kawaminami K, Horita S, Furusawa M,. Allograft glomerulitis: histologic characteristics to detect chronic humoral rejection. Transplant Proc 2005; 37: 714.
28. Tinckam KJ, Djurdjev O, Magil AB,. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68: 1866.
29. Magil AB,. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis 2005; 45: 1084.
30. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
31. Cosio FG, Gloor JM, Sethi S, Stegall MD,. Transplant glomerulopathy. Am J Transplant 2008; 8: 492.
32. Habib R, Broyer M,. Clinical significance of allograft glomerulopathy. Kidney Int Suppl 1993; 43: S95.
33. Axelsen RA, Seymour AE, Mathew TH, Canny A, Pascoe V,. Glomerular transplant rejection: a distinctive pattern of early graft damage. Clin Nephrol 1985; 23: 1.
34. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804.
35. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124.
36. Mao Q, Terasaki PI, Cai J, et al. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 2007; 7: 864.